Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04551040 · ClinicalTrials.gov registry record · Phase 1

Target Engagement of Terazosin in Healthy Adults

A Phase 1 study of Healthy, sponsored by University of Iowa.

Active
Registry status
Phase 1
Development phase
18
Enrollment target
1
Study location

NCT04551040 is a Phase 1 study of Healthy that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 18 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04551040, a Phase 1 study of Healthy, is active but no longer recruiting, sponsored by University of Iowa.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to assess the target engagement of Terazosin (TZ) in a single cohort of 6 healthy adult participants. During the study participants will undergo PET/CT scans, 7-Tesla MRI scans, blood draws, and an optional lumbar puncture (LP.)

Conditions Studied

Healthy

Interventions

  • DRUG Terazosin

Study Locations (1)

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2021-03-26
Est. Completion 2025-06-30
Phase Phase 1

Sponsor

University of Iowa

228 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04551040

The ClinicalTrials.gov registry entry for NCT04551040 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Terazosin is the first listed.

NCT04551040 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT04551040 about?

NCT04551040 is a clinical study titled "Target Engagement of Terazosin in Healthy Adults". The purpose of the study is to assess the target engagement of Terazosin (TZ) in a single cohort of 6 healthy adult participants. During the study participants will undergo PET/CT scans, 7-Tesla MRI scans, blood draws, and an optional lumbar puncture (LP.)

What is the current status of trial NCT04551040?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2021-03-26. Estimated completion is 2025-06-30.

What conditions does trial NCT04551040 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04551040?

The interventions under investigation include: Terazosin (DRUG).

Who is sponsoring clinical trial NCT04551040?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04551040 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Iowa

All trials with a study site in Iowa

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.